NuVasive names chairman and interim CEO Gregory Lucier to be its new chief executive, replacing the ousted Alex Lukianov.
NuVasive Inc. (NSDQ:NUVA) said today that it promoted its interim chief executive to the full-time spot, naming chairman Gregory Lucier CEO.
Direct Flow Medical taps the former chief at CoreValve, Daniel Lemaitre, to be its new CEO and names pharma finance vet David Boyle as CFO.
, Direct Flow Medical Inc.
, Insulet Corp.
, Integra LifeSciences Corp.
, Rivanna Medical
, Stereotaxis Inc.
NuVasive shares gain after the spinal implant maker beats expectations with its 1st-quarter numbers and launches a new platform to ensure alignment during spine surgeries.
NuVasive Inc. (NSDQ:NUVA) shares are up today on a 1st-quarter swing to black ink and the launch of its 1st major new platform in a decade.
Here's a look at some of the top legal news stories for medical device companies this week: Witness for J&J's Synthes faked credentials; Medtronic agrees to stop making SynchroMed drug pump; NuVasive settles Justice Dept. probe for $14m; Boston Scientific inks $119m pelvic mesh deal; Stryker inks $3m settlement in Howmedica reimbursement suit
, Centers for Medicare and Medicaid Services (CMS)
, Dept. of Health & Human Services (HHS)
, Dept. of Justice (DOJ)
, DePuy Synthes Spine
, Food & Drug Administration (FDA)
, Globus Medical
, Howmedica Osteonics Corp.
, Johnson & Johnson
NuVasive says it agreed to pay nearly $14 million to settle a U.S. Justice Dept. probe into possible Medicare fraud.
NuVasive Inc. (NSDQ:NUVA) today said it agreed to pay $13.8 million to settle a U.S. Justice Dept. probe into possible healthcare fraud.
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds preemption ruling in Medtronic InFuse lawsuit; Appeals court declines Medtronic's review bid in NuVasive spat; Cochlear Ltd. wins reprieve in $131m patent loss to Advanced Bionics; Arthrex loses another appeal bid in $35m loss to KFx; Supremes deny BD bid for appeal in Retractable Technologies case
A federal appeals court declines to review its decision to overturn a lost profits award to Medtronic in its long-running patent infringement war with NuVasive.